Showing results (151-160 of 282) with videos related to
Sort By:
Pageof 29
Pediatric Blood & Cancer|September 29, 2009
Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemiaMargarita Raygada, Diane C Arthur, Alan S Wayne, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemiaVivian G Oehler, Jerald P Radich, Barry Storer, et al.British Journal of Haematology|January 4, 2014
Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase chronic myeloid leukaemiaMichael W Deininger, Kenneth J Kopecky, Jerald P Radich, et al.Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategyHui Wei, Laiman Xiang, Alan S Wayne, et al.The New England Journal of Medicine|March 9, 2017
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid LeukemiaAndreas Hochhaus, Richard A Larson, François Guilhot, et al.Blood|May 12, 2017
Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysisCatherine C Smith, Amy Paguirigan, Grace R Jeschke, et al.Hematological Oncology|April 24, 2019
Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasmsTariq I Mughal, Naveen Pemmaraju, Jerald P Radich, et al.Journal of Extracellular Vesicles|March 23, 2017
Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cellsAmbrose Y Jong, Chun-Hua Wu, Jingbo Li, et al.Haematologica|July 29, 2010
Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implicationsArmin G Jegalian, Nataliya P Buxbaum, Fabio Facchetti, et al.Blood|July 1, 2004
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningFrédéric Baron, Jennifer E Baker, Rainer Storb, et al.Pageof 29